BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 39 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $81,000 | +8.0% | 17,484 | 0.0% | 0.00% | – |
Q4 2019 | $75,000 | +10.3% | 17,484 | 0.0% | 0.00% | – |
Q3 2019 | $68,000 | -1.4% | 17,484 | 0.0% | 0.00% | – |
Q2 2019 | $69,000 | -76.5% | 17,484 | -74.1% | 0.00% | -100.0% |
Q1 2019 | $293,000 | +452.8% | 67,484 | +349.9% | 0.00% | – |
Q4 2018 | $53,000 | -7.0% | 15,000 | 0.0% | 0.00% | – |
Q3 2018 | $57,000 | -3.4% | 15,000 | 0.0% | 0.00% | – |
Q2 2018 | $59,000 | -71.4% | 15,000 | -70.0% | 0.00% | -100.0% |
Q3 2017 | $206,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EAM Investors, LLC | 129,929 | $603,000 | 0.19% |
ABNER HERRMAN & BROCK LLC | 56,050 | $260,000 | 0.06% |
CFO4Life Group, LLC | 12,000 | $56,000 | 0.03% |
Spark Investment Management LLC | 12,000 | $55,000 | 0.03% |
Phoenix Holdings Ltd. | 118,533 | $534,000 | 0.03% |
HighPoint Advisor Group LLC | 13,533 | $82,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 12,500 | $58,000 | 0.02% |
ETF MANAGERS GROUP, LLC | 66,197 | $299,000 | 0.01% |
WINTON GROUP Ltd | 76,967 | $357,000 | 0.01% |
IHT Wealth Management, LLC | 13,000 | $60,000 | 0.01% |